The molecular mechanism by which ADI inhibits NSCLC metastasis involves the regulation of the PLAT/FAK/AKT pathway to suppress the migration and invasion of gefitinib-resistant PC9GR cells. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.